Dexamethasone effect on the inflammatory response of the central nervous system in bacterial meningitis

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 13 SUPPL. A, 1996, Pages 52-56

  Pérez, Carla Odio ^a  

^a National Children Hospital   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; DEXAMETHASONE; INTERLEUKIN 1BETA; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; BACTERIAL MENINGITIS; BACTERIOLOGY; CANADA; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; COSTA RICA; ENCEPHALITIS; EUROPE; FEVER; GASTROINTESTINAL HEMORRHAGE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; MEDIATOR; MENINGITIS; MORBIDITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 3142620781     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80099-3     Document Type: Conference Paper

References (15)

1. Wenger JD, Hightower AW, Facklam RR, et al, and the Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986. Report of a multistate surveillance study. J Infect Dis. 1990;102:1316-1328.
2. Saez-Llorens X, Ramilo O, Mustafa MM, et al. Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications. J Pediatr. 1990;116:671-684.
3. Wilspelwey B, Lesse AJ, Hansen EJ, Scheld WM. Haemophilus influenzae lipopolysaccharide induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest. 1988;82:1339-1340.
4. Ramilo O, Saez-Llorens X, Mertsola J, et al. Tumor necrosis factor cachectin and interleukin 1-beta initiate meningeal inflammation. J Exp Med. 1990;172:497-507.
5. Mustafa MM, Lebel MH, Ramilo O, et al. Correlation of interleukin-1-beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr. 1989;115:208-213.
6. Mustafa M, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1989;160:818-825.
7. Lebel MB, Freij BJ, Syrogiannopoulus GA, et al. Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo-controlled trials. NEJM. 1988;819:964-971.
8. Odio CM, Raingezicht T, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. NEJM. 1991;324: 1525-1531.
9. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis. 1985;151:528-534.
10. Kennedy WA, Hoyt MJ, McCracken GH Jr. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child. 1991;145:1374-1378.
11. Syrogiannopoulos GA, Lourida AN, Theodoricou MC, et al. Dexamethasone therapy for bacterial meningitis in children: 2 versus 4 day regimen. J Infect Dis. 1994;169:853-858.
12. Schaad UB, Lips V, Gnehm HE, et al. Dexamethasone therapy for bacterial meningitis in children. Lancet. 1993;342:457-461.
13. Kilpi T, Pettola H, Jauhiainen T, Kallio MJT. Oral glycerol and intravenous dexamethasone in preventing hearing impairment due to childhood bacterial meningitis. Pediatr Infect Dis J. 1995. In press.
14. Wald ER, Kaplan S, Mason E, Sabo D. Dexamethasone therapy for bacterial meningitis in children. Pediatrics. 1995. In press.
15. Geiman BJ, Smith AL. Dexamethasone and bacterial meningitis, a meta-analysis of randomised controlled trials. West J Med. 1992;157:27-31.